Authors: Erhardt, JA Ohlstein, EH Toomey, JR Gabriel, MA Willette, RN Yue, TL Barone, FC Parsons, AA

Citation: Ja. Erhardt et al., Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban, THROMB RES, 103(2), 2001, pp. 143-148

Authors: Toomey, JR Blackburn, MN Storer, BL Valocik, RE Koster, PF Feuerstein, GZ

Citation: Jr. Toomey et al., Comparing the antithrombotic efficacy of a humanized anti-factor IX(a) monoclonal antibody (SB 249417) to the low molecular weight heparin enoxaparinin a rat model of arterial thrombosis, THROMB RES, 100(1), 2000, pp. 73-79

Authors: Feuerstein, GZ Patel, A Toomey, JR Bugelski, P Nichols, AJ Church, WR Valocik, R Koster, P Baker, A Blackburn, MN

Citation: Gz. Feuerstein et al., Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats, ART THROM V, 19(10), 1999, pp. 2554-2562

Authors: Feuerstein, GZ Toomey, JR Valocik, R Koster, P Patel, A Blackburn, MN

Citation: Gz. Feuerstein et al., An inhibitory anti-factor IX antibody effectively reduces thrombus formation in a rat model of venous thrombosis, THROMB HAEM, 82(5), 1999, pp. 1443-1445